Clinical Trials in San Francisco

Showing 10441-10460 of 12,991 trials

Computer-Based Training for Cognitive Enhancement: Classroom Study

NCT00337909

The primary objective of this study is to evaluate the design and effectiveness of a computer-based training program on the memory and cognitive abilities of mature individuals undergoing healthy aging.

Aging

Posit Science Corporation94 participantsStarted Sep 2005

San Francisco, California, United States

TERMINATEDPhase 1< 1 mile

Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence

NCT01666405

The purpose of this study is to determine the effectiveness of percutaneous tibial nerve stimulation (PTNS) therapy with the Urgent® PC Neuromodulation System (Uroplasty, Inc., Minnetonka, MN, USA) for the treatment of fecal incontinence (FI).

Fecal Incontinence

Uroplasty, Inc30 participantsStarted Aug 2012

Los Angeles, California, United States • San Francisco, California, United States • Minneapolis, Minnesota, United States +3 more locations

TERMINATEDPhase 3< 1 mile

Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer

NCT00738881

This randomized phase III trial studies pemetrexed disodium to see how well it works compared with erlotinib hydrochloride as second-line therapy in treating patients with non-small cell lung cancer that has spread to other places in the body. Pemetrexed disodium and erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether pemetrexed disodium is more effective than erlotinib hydrochloride in treating advanced non-small cell lung cancer.

Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more

National Cancer Institute (NCI)23 participantsStarted Oct 2008

Scottsdale, Arizona, United States • Fort Smith, Arkansas, United States • Antioch, California, United States +266 more locations

Computer-Based Training for Cognitive Enhancement: Classroom Study

Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence

Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Find Trials by Condition in San Francisco

In Vitro Fertilization (IVF) and Acupuncture for Infertility

A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients

Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices

Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease

Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement

Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia

Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation

Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder

The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects

Safety and Effectiveness of Juvéderm® VOLUMA XC Injectable Gel for Cheek Augmentation

Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial

Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors